Telix Pharmaceuticals Limited Stock Nasdaq
Stocks
TLX
US87961M1053
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
11:58:44 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 11.70 USD | +3.22% |
|
0.00% | +56.61% |
| 08-20 | Telix Pharmaceuticals Limited, H1 2026 Earnings Call, Aug 20, 2026 | |
| 08-19 | Telix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 5.49B 3.94B 3.37B 3.15B 2.89B 5.42B 377B 37.27B 14.53B 189B 14.78B 14.46B 626B | P/E 2026 * |
246x | P/E 2027 * | 167x |
|---|---|---|---|---|---|
| Enterprise Value | 5.92B 4.24B 3.63B 3.4B 3.11B 5.84B 406B 40.18B 15.67B 204B 15.93B 15.59B 675B | EV / Sales 2026 * |
4.32x | EV / Sales 2027 * | 3.8x |
| Free-Float |
83.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | +3.22% | ||
| Current month | +18.60% | ||
| 1 month | +14.77% | ||
| 3 months | +22.57% | ||
| 6 months | +78.95% | ||
| Current year | +56.61% |
| 1 week | 11.19 |  | 12.48 |
| 1 month | 9.79 | | 12.48 |
| Current year | 6.28 | | 12.48 |
| 1 year | 6.28 | | 12.58 |
| 3 years | 6.28 | | 30.36 |
| 5 years | 6.28 | | 30.36 |
| 10 years | 6.28 | | 30.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.22% | 0.00% | - | - | 3.8B | |
| -0.74% | +3.78% | +2.62% | +23.10% | 51.61B | |
| +0.33% | -1.09% | +487.85% | +558.97% | 44.89B | |
| +0.26% | +7.50% | +37.93% | +20.33% | 42.77B | |
| -0.89% | +2.06% | +19.88% | +86.03% | 42.58B | |
| +0.88% | -3.48% | +17.20% | +57.20% | 31.82B | |
| -0.39% | +3.37% | +32.23% | +144.15% | 17.33B | |
| -1.00% | +1.36% | - | - | 16.63B | |
| +0.58% | +4.66% | +9.77% | +30.87% | 14.76B | |
| +0.28% | +2.52% | +79.07% | +47.95% | 14.09B | |
| Average | +0.22% | +4.83% | +85.82% | +121.08% | 30.72B | |
| Weighted average by Cap. | -0.16% | +5.13% | +103.41% | +139.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.37B 982M 842M 787M 721M 1.35B 93.99B 9.3B 3.63B 47.22B 3.69B 3.61B 156B | 1.58B 1.13B 968M 906M 829M 1.56B 108B 10.7B 4.17B 54.32B 4.24B 4.15B 180B |
| Net income | 25.05M 17.96M 15.38M 14.39M 13.17M 24.72M 1.72B 170M 66.31M 863M 67.42M 65.96M 2.85B | 19.91M 14.27M 12.23M 11.44M 10.47M 19.65M 1.37B 135M 52.71M 686M 53.59M 52.43M 2.27B |
| Net Debt | 429M 308M 263M 246M 226M 423M 29.43B 2.91B 1.14B 14.78B 1.15B 1.13B 48.89B | 498M 357M 306M 286M 262M 491M 34.13B 3.38B 1.32B 17.15B 1.34B 1.31B 56.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | US$11.73 | +3.53% | 133,245 |
| 26-08-21 | US$11.33 | -8.78% | 299,625 |
| 26-08-20 | US$12.42 | +2.48% | 368,572 |
| 26-08-19 | US$12.12 | +2.02% | 88,728 |
| 26-08-18 | US$11.88 | +1.28% | 43,112 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
